These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 18056156)

  • 21. Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.
    Rodríguez-López A; Pimentel-Vera LN; Espejo-Mojica AJ; Van Hecke A; Tiels P; Tomatsu S; Callewaert N; Alméciga-Díaz CJ
    J Pharm Sci; 2019 Aug; 108(8):2534-2541. PubMed ID: 30959056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practical and reliable enzyme test for the detection of mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samples.
    Camelier MV; Burin MG; De Mari J; Vieira TA; Marasca G; Giugliani R
    Clin Chim Acta; 2011 Sep; 412(19-20):1805-8. PubMed ID: 21684269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heteroallelic missense mutations of the galactosamine-6-sulfate sulfatase (GALNS) gene in a mild form of Morquio disease (MPS IVA).
    Cole DE; Fukuda S; Gordon BA; Rip JW; LeCouteur AN; Rupar CA; Tomatsu S; Ogawa T; Sukegawa K; Orii T
    Am J Med Genet; 1996 Jun; 63(4):558-65. PubMed ID: 8826435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
    Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
    Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
    Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Construction of an adenoassociated, viral derived, expression vector to correct the genetic defect in Morquio A disease].
    Gutiérrez MA; García-Vallejo F; Tomatsu S; Cerón F; Alméciga-Díaz CJ; Domínguez MC; Barrera LA
    Biomedica; 2008 Sep; 28(3):448-59. PubMed ID: 19034368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bio-Plex immunoassay measuring the quantity of lysosomal
    Chuang CK; Lin HY; Wang TJ; Huang SF; Lin SP
    BMJ Open; 2017 Jul; 7(7):e014410. PubMed ID: 28710204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morquio A syndrome: cloning, sequence, and structure of the human N-acetylgalactosamine 6-sulfatase (GALNS) gene.
    Morris CP; Guo XH; Apostolou S; Hopwood JJ; Scott HS
    Genomics; 1994 Aug; 22(3):652-4. PubMed ID: 8001980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase gene among Egyptian patients with Morquio A disease.
    Fateen EM; El Mawgoud HA; Eissa NR; Ibrahim MM; Aglan MS; Essawi ML
    Gene; 2017 Feb; 600():48-54. PubMed ID: 27825773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined adenine phosphoribosyltransferase and N-acetylgalactosamine-6-sulfate sulfatase deficiency.
    Wang L; Ou X; Sebesta I; Vondrak K; Krijt J; Elleder M; Poupetova H; Ledvinova J; Zeman J; Simmonds HA; Tischfield JA; Sahota A
    Mol Genet Metab; 1999 Sep; 68(1):78-85. PubMed ID: 10479485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
    Dũng VC; Tomatsu S; Montaño AM; Gottesman G; Bober MB; Mackenzie W; Maeda M; Mitchell GA; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):129-38. PubMed ID: 23876334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fourteen novel mucopolysaccharidosis IVA producing mutations in GALNS gene.
    Tomatsu S; Fukuda S; Cooper A; Wraith JE; Ferreira P; Di Natale P; Tortora P; Fujimoto A; Kato Z; Yamada N; Isogai K; Yamagishi A; Sukegawa K; Suzuki Y; Shimozawa N; Kondo N; Sly WS; Orii T
    Hum Mutat; 1997; 10(5):368-75. PubMed ID: 9375852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.
    Morrone A; Tylee KL; Al-Sayed M; Brusius-Facchin AC; Caciotti A; Church HJ; Coll MJ; Davidson K; Fietz MJ; Gort L; Hegde M; Kubaski F; Lacerda L; Laranjeira F; Leistner-Segal S; Mooney S; Pajares S; Pollard L; Ribeiro I; Wang RY; Miller N
    Mol Genet Metab; 2014 Jun; 112(2):160-70. PubMed ID: 24726177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.
    Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S
    Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elosulfase alfa: first global approval.
    Sanford M; Lo JH
    Drugs; 2014 Apr; 74(6):713-8. PubMed ID: 24700469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: nine novel mutations including T312S, a common allele that confers a mild phenotype.
    Yamada N; Fukuda S; Tomatsu S; Muller V; Hopwood JJ; Nelson J; Kato Z; Yamagishi A; Sukegawa K; Kondo N; Orii T
    Hum Mutat; 1998; 11(3):202-8. PubMed ID: 9521421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy.
    Donida B; Marchetti DP; Biancini GB; Deon M; Manini PR; da Rosa HT; Moura DJ; Saffi J; Bender F; Burin MG; Coitinho AS; Giugliani R; Vargas CR
    Biochim Biophys Acta; 2015 May; 1852(5):1012-9. PubMed ID: 25701642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodegradable polyethylene glycol hydrogels for sustained release and enhanced stability of rhGALNS enzyme.
    Jain E; Flanagan M; Sheth S; Patel S; Gan Q; Patel B; Montaño AM; Zustiak SP
    Drug Deliv Transl Res; 2020 Oct; 10(5):1341-1352. PubMed ID: 31994025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Umbilical mesenchymal stem cell-derived extracellular vesicles as enzyme delivery vehicle to treat Morquio A fibroblasts.
    Flanagan M; Pathak I; Gan Q; Winter L; Emnet R; Akel S; Montaño AM
    Stem Cell Res Ther; 2021 May; 12(1):276. PubMed ID: 33957983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case Report of a Japanese Boy with Morquio A Syndrome: Effects of Enzyme Replacement Therapy Initiated at the Age of 24 Months.
    Nakamura-Utsunomiya A; Nakamae T; Kagawa R; Karakawa S; Sakata S; Sakura F; Tani C; Matsubara Y; Ishino T; Tajima G; Okada S
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.